HR 2917 · 109th Congress · Foreign Trade and International Finance

To suspend temporarily the duty on formulations of Thiamethoxam, Difenoconazole, Fludioxinil, and Mefenoxam.

Introduced 2005-06-15· Sponsored by Rep. Castle, Michael N. [R-DE-At Large]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Trade.(2005-06-22)

Plain Language Summary

[AI summary unavailable — showing source text] Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2008, the duty on formulations of Thiamethoxam, Difenoconazole, Fludioxinil and Mefenoxam which contain: Thiamethoxam Technical 3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-5-methyl-N-nitro- 1,3,5-oxadiazin-4-imine), Difenoconazole Technical 1H-1,2,4-triazole, 1-[[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]- Fludioxinil Technical 1H-Pyrrole-3-carbonitrile, 4-(2,2-difluoro-1,3-benzodioxol-4-yl)- Mefenoxam Technical (R,S)-2-[(2,6-dimethylphenyl]-methoxyacetylamino]-propionic acid methyl ester.…

Summarized by Claude AI · Non-partisan · For informational purposes only